tiprankstipranks
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14)
SGX:T14
T14
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
RESEARCH TOOLSreports

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (T14) Income Statement

1 Followers

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Income Statement

Last quarter (Q4 2022), Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's total revenue was ¥2.69B, an increase of 72.71% from the same quarter last year. In Q4, Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's net income was ¥132.83M. See Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
¥ 8.25B¥ 8.25B¥ 6.91B¥ 6.60B¥ 6.99B¥ 6.36B
Cost of Revenue
¥ 4.96B¥ 4.96B¥ 4.15B¥ 4.03B¥ 4.05B¥ 3.72B
Gross Profit
¥ 3.29B¥ 3.29B¥ 2.76B¥ 2.58B¥ 2.95B¥ 2.64B
Operating Expense
¥ 2.57B¥ 2.57B¥ 2.14B¥ 1.98B¥ 2.38B¥ 2.16B
Operating Income
¥ 723.34M¥ 723.34M¥ 613.18M¥ 595.93M¥ 576.09M¥ 476.16M
Net Non Operating Interest Income Expense
¥ 42.21M¥ 42.21M¥ 44.94M¥ 24.98M¥ 6.65M¥ -3.67M
Other Income Expense
------
Pretax Income
¥ 980.19M¥ 980.19M¥ 872.81M¥ 768.06M¥ 743.15M¥ 640.63M
Tax Provision
¥ 106.93M¥ 106.93M¥ 85.93M¥ 88.40M¥ 107.79M¥ 72.84M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
¥ 861.79M¥ 861.79M¥ 769.14M¥ 661.70M¥ 625.57M¥ 561.68M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
¥ 7.53B¥ 7.53B¥ 6.29B¥ 6.01B¥ 6.43B¥ 5.88B
Net Income From Continuing And Discontinued Operation
¥ 861.79M¥ 861.79M¥ 769.14M¥ 661.70M¥ 625.57M¥ 561.68M
Normalized Income
¥ 915.19M¥ 912.83M¥ 774.21M¥ 655.03M¥ 580.65M¥ 556.45M
Interest Expense
¥ 8.69M¥ 10.27M¥ 2.94M¥ 6.66K¥ 4.89M¥ 11.38M
EBIT
¥ 990.46M¥ 990.46M¥ 875.74M¥ 768.06M¥ 748.04M¥ 652.01M
EBITDA
¥ 990.46M¥ 1.11B¥ 991.28M¥ 878.91M¥ 846.19M¥ 728.16M
Currency in CNY

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis